CB1R independent effects of cannabinoids on synaptic physiology in the CNS.

大麻素对中枢神经系统突触生理学的 CB1R 独立影响。

基本信息

  • 批准号:
    8048639
  • 负责人:
  • 金额:
    $ 21.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-03-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a basic science proposal designed to use in vitro electrophysiological and optical techniques to further our understanding of an extremely unusual form of cannabinoid dependent signaling discovered in my lab. Specifically, we have observed that cannabinoid receptor agonists potentiate action potential independent release of GABA in the dentate gyrus through a cannabinoid type I (CB1) receptor independent mechanism. Although recent years have brought an enormous wealth of new information about the specific roles of endogenous cannabinoids in CNS physiology, the effect of cannabinoid receptor agonists that we have discovered appears to be unique in numerous respects. First, it does not depend on activation of CB1, CB2, or vanilloid type I receptors, and is still present in CB1-/- animals. Second, it clearly modulates action potential independent exocytotic events without altering action potential dependent events, and third, it ultimately results in the facilitation (rather than inhibition) of exocytosis. While our preliminary data represent significant progress towards characterizing a new role for cannabinoids in CNS physiology, many fundamental questions regarding this new phenomenon remain. Therefore this proposal requests funds to continue our investigation in this area through implementation of two Specific Aims. Aim 1 will test the hypothesis that cannabinoid mediated facilitation of action potential independent exocytosis depends on a specific ligand receptor interaction with an as yet unidentified GPCR. Specifically, we hypothesize that a G1s -> AC -> cAMP -> PKA signaling cascade is involved. Aim 2 will test the hypothesis that anandamide or one of its metabolites will be the most effective endogenously available ligand for facilitation of action potential independent release, and that the best agonists will work well within a physiologically relevant concentration range. Collectively, these Aims are designed to provide data that have the potential to clearly establish the significance of our findings for the cannabinoid field, and that will directly facilitate a longer term and larger scale investigation of the phenomenon. PUBLIC HEALTH RELEVANCE: Nearly all the known central effects of endogenous cannabinoids are thought to be mediated by activation of a single type of receptor, the CB1 cannabinoid receptor. We have recently discovered a highly novel form of cannabinoid mediated signaling that does not depend on CB1 receptor activation, and that has unique effects on CNS physiology. The current proposal is designed to address several fundamental questions about this new signaling system that we hope will ultimately establish the overall significance (and potential) of the finding.
描述(申请人提供):这是一项基础科学提案,旨在使用体外电生理和光学技术来加深我们对在我的实验室中发现的一种极其不寻常的大麻依赖信号形式的理解。具体地说,我们观察到大麻素受体激动剂通过大麻素I型受体(CB1)受体非依赖机制增强动作电位非依赖于齿状回的GABA释放。尽管近年来关于内源性大麻素在中枢神经系统生理学中的具体作用带来了大量的新信息,但我们发现的大麻素受体激动剂的作用似乎在许多方面都是独一无二的。首先,它不依赖于CB1、CB2或香草素I型受体的激活,并且仍然存在于CB1-/-动物中。第二,它明显地调节动作电位非依赖性胞吐事件,而不改变动作电位依赖性事件;第三,它最终导致胞吐作用的促进(而不是抑制)。虽然我们的初步数据表明,在表征大麻素在中枢神经系统生理学中的新作用方面取得了重大进展,但关于这一新现象的许多基本问题仍然存在。因此,这项提案要求提供资金,通过执行两个具体目标继续我们在这一领域的调查。目的1将验证一种假说,即大麻素介导的动作电位非依赖性胞吐作用依赖于一个特定的配体受体与一个尚未确定的GPCR的相互作用。具体地说,我们假设G1S->AC->cAMP->PKA信号级联参与其中。目标2将验证这样的假设,即阿南达胺或其代谢物之一将是促进动作电位非依赖性释放的最有效的内源性可用配体,并且最好的激动剂将在生理相关的浓度范围内发挥良好的作用。总而言之,这些目的是为了提供数据,这些数据有可能清楚地确定我们的研究结果对大麻素领域的意义,并将直接促进对这一现象的长期和更大规模的调查。 与公共卫生相关:几乎所有已知的内源性大麻素的中枢效应都被认为是通过激活单一类型的受体--CB1大麻素受体--介导的。我们最近发现了一种非常新颖的大麻素介导的信号传递形式,它不依赖于CB1受体的激活,并且对中枢神经系统的生理有独特的影响。目前的提案旨在解决有关这一新信号系统的几个基本问题,我们希望这些问题最终将确立这一发现的总体意义(和潜力)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES J FRAZIER其他文献

CHARLES J FRAZIER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES J FRAZIER', 18)}}的其他基金

Brain-gut-retina axis in diabetic retinopathy
糖尿病视网膜病变中的脑-肠-视网膜轴
  • 批准号:
    10595142
  • 财政年份:
    2023
  • 资助金额:
    $ 21.98万
  • 项目类别:
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders
与情绪/焦虑障碍相关的中枢催产素信号的新方面
  • 批准号:
    9014566
  • 财政年份:
    2015
  • 资助金额:
    $ 21.98万
  • 项目类别:
Novel Aspects of Central Oxytocin Signaling Relevant to Mood/Anxiety Disorders
与情绪/焦虑障碍相关的中枢催产素信号的新方面
  • 批准号:
    8888289
  • 财政年份:
    2015
  • 资助金额:
    $ 21.98万
  • 项目类别:
CB1R independent effects of cannabinoids on synaptic physiology in the CNS.
大麻素对中枢神经系统突触生理学的 CB1R 独立影响。
  • 批准号:
    8225252
  • 财政年份:
    2011
  • 资助金额:
    $ 21.98万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus.
齿状回中的内源性大麻素和补品 GABA。
  • 批准号:
    7093652
  • 财政年份:
    2005
  • 资助金额:
    $ 21.98万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus
齿状回中的内源性大麻素和补品 GABA
  • 批准号:
    7656750
  • 财政年份:
    2005
  • 资助金额:
    $ 21.98万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus
齿状回中的内源性大麻素和补品 GABA
  • 批准号:
    7460588
  • 财政年份:
    2005
  • 资助金额:
    $ 21.98万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus.
齿状回中的内源性大麻素和补品 GABA。
  • 批准号:
    7473458
  • 财政年份:
    2005
  • 资助金额:
    $ 21.98万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus
齿状回中的内源性大麻素和补品 GABA
  • 批准号:
    7242587
  • 财政年份:
    2005
  • 资助金额:
    $ 21.98万
  • 项目类别:
Endocannabinoids and tonic GABA in the dentate gyrus
齿状回中的内源性大麻素和补品 GABA
  • 批准号:
    6903677
  • 财政年份:
    2005
  • 资助金额:
    $ 21.98万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 21.98万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了